ORINY (ORINY) Stock Price & Analysis
ORINY (ORINY) rose 0.00% to USD 43.02 as of July 25, 2026 at 01:47 UTC, according to Nexqual real-time market data.
ORINY last closed at USD 43.02; the session ranged USD 39.02–39.02 on volume of 3 shares. Market capitalization is $12.12B, with a 52-week range of USD 30.89–43.22 (PNK). Source: Nexqual, July 25, 2026 at 01:47 UTC.
Key Statistics (as of July 25, 2026 at 01:47 UTC)
| Price | USD 43.02 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 43.02 |
| Open | USD 39.02 |
| Day Range | USD 39.02 – 39.02 |
| 52-Week Range | USD 30.89 – 43.22 |
| Volume | 3 shares |
| Market Cap | $12.12B |
| Exchange | PNK |
Technical Analysis (ORINY)
Nexqual's technical model rates ORINY "BUY" based on 5 bullish and 3 bearish signals across 124 daily candles, as of July 25, 2026 at 01:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 91.04 (overbought) |
| vs SMA50 | Above (USD 38.78) |
| MACD | 0.96 (positive) |
Analyst Ratings (ORINY)
Wall Street analysts rate ORINY "None", per Nexqual as of July 25, 2026 at 01:47 UTC.
| Consensus Rating | None |
|---|
Earnings (ORINY)
| Revenue Estimate | $532.19M |
|---|
Source: Nexqual, July 25, 2026 at 01:47 UTC.
Financials & Fundamentals (ORINY)
| Total Revenue | $2.06B |
|---|---|
| Revenue Growth (YoY) | +25.20% |
| Gross Margin | +65.93% |
| Operating Margin | +33.84% |
| Profit Margin | +28.53% |
| ROE | +53.65% |
| Debt / Equity | 10.46 |
| Current Ratio | 2.64 |
| Total Cash | $130.20M |
| Total Debt | $132.70M |
| Free Cash Flow | $268.68M |
Source: Nexqual, July 25, 2026 at 01:47 UTC.
Financial Health Score (ORINY)
Nexqual rates ORINY's overall financial health "Strong" across five dimensions, as of July 25, 2026 at 01:47 UTC.
| Growth | Strong — Revenue +23% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 66%, operating 34% |
| Balance Sheet | Strong — $130M cash vs $133M debt |
| Cash Flow | Solid — FCF $269M, 14% margin |
| Efficiency | Strong — ROE 54%, ROA 26.3% |
Ownership (ORINY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 218.99M |
| Float | 246.23M |
Source: Nexqual, July 25, 2026 at 01:47 UTC.
Leadership (ORINY)
ORINY is led by Liisa Hurme (age 58), President, CEO & Chairman of Executive Management Board, per Nexqual as of July 25, 2026 at 01:47 UTC.
| President, CEO & Chairman of Executive Management Board | Liisa Hurme (age 58) |
|---|---|
| CFO & Member of Group Executive Management Board | Rene Lindell M.Sc. (age 49) |
| Executive Vice President of Innovative Medicines & Member of Management Board | Berkeley Vincent (age 48) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IPSEY | Ipsen S.A. | USD 47.11 | ▲ 0% |
| UCBJY | UCB S.A. | USD 139.01 | ▼ 0.04% |
| OUKPY | Metso OYJ | USD 9.56 | ▲ 7.11% |
| RANJY | Randstad NV | USD 20.62 | ▼ 0.48% |
| TLTZY | Tele2 AB | USD 8.37 | ▲ 1.94% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:47 UTC. This page is informational and not investment advice.